12/19
08:15 am
mrkr
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma [Yahoo! Finance]
Medium
Report
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma [Yahoo! Finance]
12/19
08:11 am
mrkr
Marker Therapeutics Announces $16.1 Million Private Placement [Yahoo! Finance]
Medium
Report
Marker Therapeutics Announces $16.1 Million Private Placement [Yahoo! Finance]
12/19
08:06 am
mrkr
Marker Therapeutics Announces $16.1 Million Private Placement
Medium
Report
Marker Therapeutics Announces $16.1 Million Private Placement
12/19
08:05 am
mrkr
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
Medium
Report
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
12/17
07:32 am
mrkr
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer [Yahoo! Finance]
Medium
Report
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer [Yahoo! Finance]
12/17
07:00 am
mrkr
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
Low
Report
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
12/10
08:30 am
mrkr
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
Low
Report
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
12/6
08:30 am
mrkr
Marker Therapeutics Leads 3 Noteworthy US Penny Stocks [Yahoo! Finance]
Low
Report
Marker Therapeutics Leads 3 Noteworthy US Penny Stocks [Yahoo! Finance]
11/26
11:09 am
mrkr
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit [Yahoo! Finance]
Low
Report
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit [Yahoo! Finance]
11/26
11:00 am
mrkr
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
Low
Report
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
11/14
04:37 pm
mrkr
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
High
Report
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
11/14
04:30 pm
mrkr
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
High
Report
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/21
01:14 pm
mrkr
Marker Therapeutics, Inc. (NASDAQ: MRKR) had its price target raised by analysts at LADENBURG THALM/SH SH from $11.00 to $19.00. They now have a "buy" rating on the stock.
Low
Report
Marker Therapeutics, Inc. (NASDAQ: MRKR) had its price target raised by analysts at LADENBURG THALM/SH SH from $11.00 to $19.00. They now have a "buy" rating on the stock.